Neuland Laboratories Ltd Financial Statement
*All values are in Rs. Cr
| Particulars | Mar 2025 | Dec 2024 | Sep 2024 |
|---|---|---|---|
| Revenue | 335.82 | 457.72 | 315.18 |
| Operating Expense | 277.61 | 311.66 | 249.50 |
| Net Profit | 27.73 | 101.39 | 31.96 |
| Net Profit Margin | 8.26 | 22.15 | 10.14 |
| Earning Per Share | 21.62 | 79.03 | 24.91 |
| EBIDTA | 52.91 | 144.83 | 61.30 |
| Effective Tax Rate | 10.20 | 17.06 | 18.59 |
| Particulars | Mar 2025 |
|---|---|
| Revenue | 335.82 |
| Operating Expense | 277.61 |
| Net Profit | 27.73 |
| Net Profit Margin | 8.26 |
| Earning Per Share | 21.62 |
| EBIDTA | 52.91 |
| Effective Tax Rate | 10.20 |
*All values are in Rs. Cr
Standalone
Consolidated
| Particulars | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|
| Total Revenue Annual | 1,558.58 | 1,191.20 | 951.08 |
| Operating Expenses Annual | 1,096.66 | 919.89 | 808.88 |
| Operating Profit Annual | 474.47 | 281.06 | 144.27 |
| Interest Annual | 14.00 | 13.07 | 13.49 |
| Depreciation | 58.64 | 51.52 | 47.56 |
| Net Profit Annual | 299.60 | 163.12 | 63.53 |
| Tax Annual | 101.17 | 52.09 | 18.21 |
| Particulars | Mar 2024 |
|---|---|
| Total Revenue Annual | 1,558.58 |
| Operating Expenses Annual | 1,096.66 |
| Operating Profit Annual | 474.47 |
| Interest Annual | 14.00 |
| Depreciation | 58.64 |
| Net Profit Annual | 299.60 |
| Tax Annual | 101.17 |
*All values are in Rs. Cr
Standalone
Consolidated
| Particulars | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|
| Cash Flow at the Beginning | 44.96 | 3.72 | 1.12 |
| Cash Flow from Operations | 260.06 | 238.53 | 60.41 |
| Cash Flow from Investing | -149.67 | -61.50 | -95.53 |
| Cash Flow from Financing | -69.28 | -135.80 | 37.72 |
| Cash Flow at the End | 86.07 | 44.96 | 3.72 |
| Particulars | Mar 2024 |
|---|---|
| Cash Flow at the Beginning | 44.96 |
| Cash Flow from Operations | 260.06 |
| Cash Flow from Investing | -149.67 |
| Cash Flow from Financing | -69.28 |
| Cash Flow at the End | 86.07 |
*All values are in Rs. Cr
Standalone
Consolidated
| Particulars | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|
| PBDIT Margin (%) | 30.44 | 23.59 | 15.17 |
| PBIT Margin (%) | 26.61 | 19.16 | 10.01 |
| PBT Margin (%) | 24.71 | 17.69 | 9.27 |
| Net PROFIT Margin (%) | 19.22 | 13.69 | 6.68 |
| Return On Networth / Equity (%) | 26.48 | 17.90 | 7.86 |
| Return On Networth /Employed (%) | 33.13 | 20.64 | 9.24 |
| Return On Assets (%) | 23.84 | 14.79 | 6.15 |
| Total Debt / Equity (X) | 0.10 | 0.20 | 0.26 |
| Asset Turnover Ratio (%) | 1.24 | 1.08 | 0.92 |
| Particulars | Mar 2024 |
|---|---|
| PBDIT Margin (%) | 30.44 |
| PBIT Margin (%) | 26.61 |
| PBT Margin (%) | 24.71 |
| Net PROFIT Margin (%) | 19.22 |
| Return On Networth / Equity (%) | 26.48 |
| Return On Networth /Employed (%) | 33.13 |
| Return On Assets (%) | 23.84 |
| Total Debt / Equity (X) | 0.10 |
| Asset Turnover Ratio (%) | 1.24 |
*All values are in Rs. Cr
Standalone
Consolidated
| Particulars | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|
| Fixed Assets Annual | 804.63 | 738.19 | 747.70 |
| Total Current Assets Annual | 919.47 | 760.34 | 579.25 |
| Non Current Assets Annual | 911.46 | 819.00 | 802.87 |
| Total Shareholders Funds Annual | 1,276.54 | 988.36 | 835.57 |
| Total Assets Annual | 1,830.93 | 1,579.34 | 1,382.12 |
| Particulars | Mar 2024 |
|---|---|
| Fixed Assets Annual | 804.63 |
| Total Current Assets Annual | 919.47 |
| Non Current Assets Annual | 911.46 |
| Total Shareholders Funds Annual | 1,276.54 |
| Total Assets Annual | 1,830.93 |
EPS (INR)
Expected
21.56
Reported
21.67
Surprise
0.51%
Dec 2024
EPS beaten by 0.51%
Sep 2024
EPS beaten by 0.55%
Jun 2024
EPS beaten by 0.55%
